Michelle Cheng is a health economist and serves as a Research Associate. She completed her master’s degree in health economics and outcomes research (HEOR) from the Bloomberg School of Public Health at Johns Hopkins University. She was also a researcher at the JHU Drug Access and Affordability Initiative, conducting studies in HEOR to evaluate new healthcare technologies and inform health policy transformation. Formerly, she worked in the pharmaceutical industry for about three years and was responsible for medical communication for branches in southeast Asia. The therapeutic areas included but were not limited to – diabetes, infectious disease and vaccine. Before that, she was a pharmacist serving in a clinic setting.
